SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-426120
Filing Date
2012-10-17
Accepted
2012-10-17 17:03:29
Documents
3
Period of Report
2012-10-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d427983d8k.htm 8-K 20651
2 PRESS RELEASE d427983dex991.htm EX-99.1 8869
3 GRAPHIC g427983g36h97.jpg GRAPHIC 2001
  Complete submission text file 0001193125-12-426120.txt   33798
Mailing Address 12270 WILKINS AVENUE ROCKVILLE MD 20852
Business Address 12270 WILKINS AVENUE ROCKVILLE MD 20852 301-770-3099
NABI BIOPHARMACEUTICALS (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 121148903
SIC: 2836 Biological Products, (No Diagnostic Substances)